- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML ; volume:8 ; number:1 ; day:17 ; month:9 ; year:2018 ; pages:1-14 ; date:12.2018
Scientific reports ; 8, Heft 1 (17.9.2018), 1-14, 12.2018
- Creator
-
Banús-Mulet, Antònia
- Contributor
-
Etxabe, Amaia
Cornet-Masana, Josep Maria
Torrente, Miguel Ángel
Lara-Castillo, María Carmen
Palomo, Laura
Nomdedeu, Meritxell
Díaz-Beyá, Marina
Solé, Francesc
Nomdedeu, Benet
Esteve, Jordi
Risueño, Ruth M.
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-32306-4
- URN
-
urn:nbn:de:101:1-2018102814251847831010
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Banús-Mulet, Antònia
- Etxabe, Amaia
- Cornet-Masana, Josep Maria
- Torrente, Miguel Ángel
- Lara-Castillo, María Carmen
- Palomo, Laura
- Nomdedeu, Meritxell
- Díaz-Beyá, Marina
- Solé, Francesc
- Nomdedeu, Benet
- Esteve, Jordi
- Risueño, Ruth M.
- SpringerLink (Online service)
Other Objects (12)
MDS
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells
The prognostic and therapeutic potential of HO-1 in leukemia and MDS
The role of serotonin 1B in the representation of outcomes
Zyklische MDS-Codes
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
G1-Ber. Isotopengeologie MDS
Graphenzeichnen mit hardwarebeschleunigter MDS
GATA2 deficiency and MDS/AML : : experimental strategies for disease modelling and future therapeutic prospects
The macrophage as therapeutic target
AKT kinases as therapeutic targets
MDS
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells
The prognostic and therapeutic potential of HO-1 in leukemia and MDS
The role of serotonin 1B in the representation of outcomes
Zyklische MDS-Codes
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
G1-Ber. Isotopengeologie MDS
Graphenzeichnen mit hardwarebeschleunigter MDS
GATA2 deficiency and MDS/AML : : experimental strategies for disease modelling and future therapeutic prospects
The macrophage as therapeutic target
AKT kinases as therapeutic targets
MDS
Curcumin as an Epigenetic Therapeutic Agent in Myelodysplastic Syndromes (MDS)
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells
The prognostic and therapeutic potential of HO-1 in leukemia and MDS
The role of serotonin 1B in the representation of outcomes
Zyklische MDS-Codes
Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose
G1-Ber. Isotopengeologie MDS
Graphenzeichnen mit hardwarebeschleunigter MDS
GATA2 deficiency and MDS/AML : : experimental strategies for disease modelling and future therapeutic prospects
The macrophage as therapeutic target